Home / Pharmaceutical company intelligence
ARP (PVT) Limited logo
Pharmaceutical company intelligence

ARP (PVT) Limited

Private pharmaceutical manufacturer · Rawat · Pakistan

Islamabad/Rawat pharmaceutical manufacturer with a fully licensed manufacturing facility and nationwide sales and support network.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date3 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
ARP (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
Plot No. 12 & 12A, Street W-3, National Industrial Zone (RCCI), Rawat, Islamabad, Pakistan
Phone
+92 51 4499103
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000682 84 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx85public portfolio records represented
REG74unique registrations represented
IDX84indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER0registry-verified exact registrations
PKR83current validated price records
G31generic molecules in indexed catalogue
DF8dosage-form groups
TA9therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage98%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixARP (PVT) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 23 Sep 2026Anti-infectives44 · 52%CNS & mental health24 · 29%Gastrointestinal & hepatology7 · 8%Oncology & immunology4 · 5%Respiratory & allergy1 · 1%Dermatology1 · 1%Fluids & supportive care1 · 1%Other therapeutic areas2 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioARP (PVT) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 23 Sep 202684presentationsTablet38 · 45%Capsule16 · 19%Injection16 · 19%Suspension6 · 7%Infusion3 · 4%Cream2 · 2%Other forms3 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionARP (PVT) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 23 Sep 202681comparable productsBelow peer median66 · 81%Near peer median11 · 14%Above peer median4 · 5%Company median price position-12.8%Lowest-price equivalents4Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsARP (PVT) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,25 shared81% overlapBio-Labs(Pvt) Ltd24 shared77% overlapPharmasol (Pvt) Ltd.22 shared71% overlapM/s. Genix Pharma (Pvt) Ltd.21 shared68% overlapNeutro Pharma (Pvt.) Ltd.,21 shared68% overlapCCL Pharmaceuticals (Pvt.) Limited19 shared61% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives44 products · 52%
CNS & mental health24 products · 29%
Gastrointestinal & hepatology7 products · 8%
Oncology & immunology4 products · 5%
Respiratory & allergy1 products · 1%
Dermatology1 products · 1%
Fluids & supportive care1 products · 1%
Hematology & thrombosis1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins15 products · 18%
Antipsychotics13 products · 15%
SSRI antidepressants11 products · 13%
Fluoroquinolone antibacterials7 products · 8%
Antifungals6 products · 7%
Macrolide antibacterials5 products · 6%
Immunosuppressants / immunomodulators4 products · 5%
Oxazolidinone antibacterials4 products · 5%
Formulation footprint

Dosage forms

Tablet38 products
Capsule16 products
Injection16 products
Suspension6 products
Infusion3 products
Cream2 products
Sachet2 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AraxoneCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 AriximeCefixime 5presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #3 ArepineQuetiapine 4presentations 100 mg, 25 mg · Tablet #4 EsitilEscitalopram 4presentations 10 mg, 20 mg · Tablet #5 ImucurbTacrolimus 4presentations 0.5 mg, 1 mg · Capsule #6 InfecnilCiprofloxacin 4presentations 200 mg/100 mL, 250 mg, 500 mg, 750 mg · Infusion, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median6681% of comparable products
Near market median11within ±5% of median
Above market median45% of comparable products
Lowest-price equivalents4ties included
Company median price position -12.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Roxidep 20 mgParoxetine · Tablet · 10s PKR 51.09/tablet-28.9% vs market median Infecnil 200 mg/100 mLCiprofloxacin · IV infusion · 100ml PKR 1.66/mL-28.1% vs market median Aromep 40 mgOmeprazole · Injection · 1s PKR 403.85/vial/unit-27.8% vs market median Esitil 20 mgEscitalopram · Tablet · 28s PKR 45.61/tablet-24.2% vs market median Imucurb 1 mgTacrolimus · Capsule · 30s PKR 78.33/capsule-19.6% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 25shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 24shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 22shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 21shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 21shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 19shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers73Distinct registrations among indexed, published, presentation-validated products only
Verified price observations84
Products with a verified price84
Products with multiple price observations0
Source records with multiple versions84
Latest portfolio source check22 Sep 2026
Latest effective price date3 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

74 unique registration(s) · 84 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acidease 40mg InjectionRegistry verified Esomeprazole as sodium — — — 111839Official source ↗ No indexed price — —
Antibac-Skin Mupirocin 2% Cream 15g 079491 PKR 245.00 PKR 16.33/g Near median
Aramox Moxifloxacin 400 mg Tablet 1x5s 079462 PKR 786.82 PKR 157.36/tablet 15% below median
Arataxime Cefotaxime 250 mg Injection 1s 062948 PKR 99.39 PKR 99.39/vial/unit 6% below median
Arataxime Cefotaxime 500 mg Injection 1s 062949 PKR 197.19 PKR 197.19/vial/unit 24% above median
Arataxime Cefotaxime 1 g Injection 1s 062950 PKR 286.80 PKR 286.80/vial/unit Near median
Araxone Ceftriaxone 250 mg Injection 1s 062942 PKR 167.31 PKR 167.31/vial/unit 13% below median
Araxone Ceftriaxone 500 mg Injection 1s 062943 PKR 304.74 PKR 304.74/vial/unit 7% below median
Araxone Ceftriaxone 1 g Injection 1s 062944 PKR 531.72 PKR 531.72/vial/unit 12% below median
Araxone Ceftriaxone 250 mg Injection 1s 062945 PKR 167.31 PKR 167.31/vial/unit 13% below median
Araxone Ceftriaxone 500 mg Injection 1s 062946 PKR 304.74 PKR 304.74/vial/unit 7% below median
Araxone Ceftriaxone 1 g Injection 1s 062947 PKR 531.72 PKR 531.72/vial/unit 12% below median
Araxone Ceftriaxone 2 g Injection 1s 098215 PKR 745.41 PKR 745.41/vial/unit 8% below median
Arepine Quetiapine 100 mg Tablet 10's 116414 PKR 646.23 PKR 64.62/tablet 13% below median
Arepine Quetiapine 25 mg Tablet 30's 116417 PKR 646.23 PKR 21.54/tablet Near median
Arepine Quetiapine 25 mg Tablet 10's 116417 PKR 215.41 PKR 21.54/tablet Near median
Arepine Quetiapine 25 mg Tablet 20's 116417 PKR 430.82 PKR 21.54/tablet Near median
Arepine XR Quetiapine 300 mg Tablet 10's 116415 PKR 1,395.85 PKR 139.59/tablet Near median
Arepine XR Quetiapine 150 mg Extended-release tablet 10's 116416 PKR 837.94 PKR 83.79/tablet Near median
Arixime Cefixime 200 mg Capsule 1x5s 062960 PKR 273.32 PKR 54.66/capsule 13% below median
Arixime Cefixime 200 mg Capsule 1x10s 062960 PKR 518.48 PKR 51.85/capsule 17% below median
Arixime Cefixime 400 mg Capsule 1x5s 062961 PKR 538.35 PKR 107.67/capsule Near median
Arixime Cefixime 100 mg/5 mL Dry suspension 30ml 062962 PKR 298.16 PKR 9.94/mL 5% below median
Arixime Cefixime 200 mg/5 mL Dry suspension 30ml 062963 PKR 537.76 PKR 17.93/mL 40% above median
Armutine Acetylcysteine 200 mg Sachet 30's 116425 PKR 581.61 PKR 19.39/sachet 24% above median
Aromep Omeprazole 20 mg Capsule 14s 079576 PKR 238.53 PKR 17.04/capsule 14% below median
Aromep Omeprazole 40 mg Capsule 14s 079577 PKR 414.13 PKR 29.58/capsule 15% below median
Aromep Omeprazole 40 mg Injection 1s 111840 PKR 403.85 PKR 403.85/vial/unit 28% below median
Calciderm Calcipotriol 0.005% Ointment 30g 079488 PKR 1,192.03 PKR 39.73/g 10% below median
Co-flon Olanzapine + Fluoxetine 6 mg + 25 mg Capsule 14s 098197 PKR 390.77 PKR 27.91/capsule 10% below median
Co-flon Olanzapine + Fluoxetine 3 mg + 25 mg Capsule 14s 098206 PKR 233.04 PKR 16.65/capsule 8% below median
Co-flon Olanzapine + Fluoxetine 12 mg + 25 mg Capsule 10s 098207 PKR 466.06 PKR 46.61/capsule 9% below median
Contrazole Fluconazole 150 mg Capsule 1x1s 079469 PKR 247.37 PKR 247.37/capsule 6% below median
Contrazole Fluconazole 50 mg/5 mL Dry suspension 35ml 079475 PKR 347.87 PKR 9.94/mL 16% below median
Contrazole Fluconazole 200 mg Capsule 4s 098213 PKR 860.41 PKR 215.10/capsule 8% below median
Electrofix Sodium chloride 13.5 g Sachet 20s 079481 PKR 496.62 PKR 24.83/sachet No comparator
Esitil Escitalopram 10 mg Tablet 1x14s 079466 PKR 644.98 PKR 46.07/tablet 13% below median
Esitil Escitalopram 10 mg Tablet 1x10s 079466 PKR 460.70 PKR 46.07/tablet 13% below median
Esitil Escitalopram 20 mg Tablet 28s 098196 PKR 1,277.18 PKR 45.61/tablet 24% below median
Esitil Escitalopram 20 mg Tablet 14s 098196 PKR 766.31 PKR 54.74/tablet 9% below median
Ferochel Deferasirox 500 mg Dispersible tablet 28s 092080 PKR 12,397.14 PKR 442.76/tablet 7% below median
Fetaclom Clomifene citrate 50 mg Tablet 10s 099215 PKR 357.80 PKR 35.78/tablet 15% below median
Glyvanq Vancomycin 500 mg Injection 1s 111841 PKR 1,019.72 PKR 1,019.72/vial/unit 19% below median
Glyvanq Vancomycin 1 g Injection 1s 111842 PKR 1,646.13 PKR 1,646.13/vial/unit 18% below median
Imucurb Tacrolimus 0.5 mg Capsule 30s 092077 PKR 1,410.00 PKR 47.00/capsule 18% below median
Imucurb Tacrolimus 0.5 mg Capsule 10s 092077 PKR 510.87 PKR 51.09/capsule 11% below median
Imucurb Tacrolimus 1 mg Capsule 30s 092078 PKR 2,350.00 PKR 78.33/capsule 20% below median
Imucurb Tacrolimus 1 mg Capsule 10s 092078 PKR 851.45 PKR 85.15/capsule 13% below median
Infecnil Ciprofloxacin 500 mg Tablet 1x10s 079459 PKR 356.14 PKR 35.61/tablet 17% below median
Infecnil Ciprofloxacin 250 mg Tablet 1x10s 097399 PKR 215.35 PKR 21.54/tablet 15% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). ARP (PVT) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/arp-pvt-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.